Details for 2019727216
Up to date per 03.04.2026
Actions
Details for 2019727216
Granted/Registered
European Patent
17.03.2021 A
23.08.2023 B1
11.05.2018
US
201862670253 P
A61K 31/472 20060101AFI20191116BHEP
Owner
Xenon Pharmaceuticals Inc.200-3650 Gilmore Way Burnaby, British Columbia V5G 4W8CA
Representative
Representative
Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT
Inventor
BEATCH, Gregory N.6994 Hycroft Road West Vancouver, British Columbia V7W 2H8CA
Information about Fees